Why LogicBio (LOGC) Stock Surged 13% In After-Hour Trading?
Shares of the clinical-stage genetic medicines company LogicBio Therapeutics Inc. (NASDAQ: LOGC) get traction in after-hours trading on Monday when it has gained 13.07% after the ring of the bell. However, during the normal trading, the stock has lost -6.02% to close the regular session at $7.96. Get the hottest stocks to trade every day […]